161 related articles for article (PubMed ID: 15629478)
21. Identification of endogenously phosphorylated KSP sites in the high-molecular-weight rat neurofilament protein.
Elhanany E; Jaffe H; Link WT; Sheeley DM; Gainer H; Pant HC
J Neurochem; 1994 Dec; 63(6):2324-35. PubMed ID: 7964754
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene.
Figlewicz DA; Rouleau GA; Krizus A; Julien JP
Gene; 1993 Oct; 132(2):297-300. PubMed ID: 8224877
[TBL] [Abstract][Full Text] [Related]
23. Variation of the neurofilament medium KSP repeat sub-domain across mammalian species: implications for altering axonal structure.
Barry DM; Carpenter C; Yager C; Golik B; Barry KJ; Shen H; Mikse O; Eggert LS; Schulz DJ; Garcia ML
J Exp Biol; 2010 Jan; 213(1):128-36. PubMed ID: 20008369
[TBL] [Abstract][Full Text] [Related]
24. Canine motor neuron disease: clinicopathologic features and selected indicators of oxidative stress.
Green SL; Bouley DM; Pinter MJ; Cork LC; Vatassery GT
J Vet Intern Med; 2001; 15(2):112-9. PubMed ID: 11300593
[TBL] [Abstract][Full Text] [Related]
25. Changes in size of motor axons in hereditary canine spinal muscular atrophy.
Cork LC; Struble RG; Gold BG; DiCarlo C; Fahnestock KE; Griffin JW; Price DL
Lab Invest; 1989 Sep; 61(3):333-42. PubMed ID: 2770248
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency.
Ameratunga R; Winkelstein JA; Brody L; Binns M; Cork LC; Colombani P; Valle D
J Immunol; 1998 Mar; 160(6):2824-30. PubMed ID: 9510185
[TBL] [Abstract][Full Text] [Related]
27. Hereditary canine spinal muscular atrophy: an animal model of motor neuron disease.
Cork LC
Can J Neurol Sci; 1991 Aug; 18(3 Suppl):432-4. PubMed ID: 1933694
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent selective suppression of light (NFL) and medium (NFM) but not heavy (NFH) molecular weight neurofilament mRNA levels in acute aluminum neurotoxicity.
Strong MJ; Mao K; Nerurkar VR; Wakayama I; Yanagihara R; Garruto RM
Mol Cell Neurosci; 1994 Aug; 5(4):319-26. PubMed ID: 7804601
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning of the cDNA of canine homeodomain-interacting protein kinase 2.
Lee SY; Chung JY; Shin IS; Choi EW; Hwang CY; Youn HY; Han HR
J Vet Sci; 2005 Jun; 6(2):141-5. PubMed ID: 15933434
[TBL] [Abstract][Full Text] [Related]
31. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog.
Lingaas F; Comstock KE; Kirkness EF; Sørensen A; Aarskaug T; Hitte C; Nickerson ML; Moe L; Schmidt LS; Thomas R; Breen M; Galibert F; Zbar B; Ostrander EA
Hum Mol Genet; 2003 Dec; 12(23):3043-53. PubMed ID: 14532326
[TBL] [Abstract][Full Text] [Related]
32. Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation.
Sánchez I; Hassinger L; Sihag RK; Cleveland DW; Mohan P; Nixon RA
J Cell Biol; 2000 Nov; 151(5):1013-24. PubMed ID: 11086003
[TBL] [Abstract][Full Text] [Related]
33. Canine CD20 gene.
Kano R; Inoiue C; Okano H; Yamazaki J; Takahashi T; Watari T; Tokuriki M; Hasegawa A
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):265-8. PubMed ID: 16061290
[TBL] [Abstract][Full Text] [Related]
34. Hereditary canine spinal muscular atrophy: a canine model of human motor neuron disease.
Cork LC; Adams RJ; Griffin JW; Price DL
Prog Clin Biol Res; 1982; 94():449-58. PubMed ID: 6181529
[No Abstract] [Full Text] [Related]
35. Canine COL4A3 and COL4A4: sequencing, mapping and genomic organization.
Wiersma AC; Millon LV; Hestand MS; Van Oost BA; Bannasch DL
DNA Seq; 2005 Aug; 16(4):241-51. PubMed ID: 16147883
[TBL] [Abstract][Full Text] [Related]
36. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
Angelopoulou K; Prassas I; Yousef GM
Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
[TBL] [Abstract][Full Text] [Related]
37. Deleting the phosphorylated tail domain of the neurofilament heavy subunit does not alter neurofilament transport rate in vivo.
Yuan A; Nixon RA; Rao MV
Neurosci Lett; 2006 Jan; 393(2-3):264-8. PubMed ID: 16266786
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the phosphorylation sites of the squid (Loligo pealei) high-molecular-weight neurofilament protein from giant axon axoplasm.
Jaffe H; Sharma P; Grant P; Pant H
J Neurochem; 2001 Feb; 76(4):1022-31. PubMed ID: 11181821
[TBL] [Abstract][Full Text] [Related]
39. Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit.
Giasson BI; Mushynski WE
J Neurosci; 1997 Dec; 17(24):9466-72. PubMed ID: 9391002
[TBL] [Abstract][Full Text] [Related]
40. Protein aggregate-containing neuron-like cells are differentiated from bone marrow mesenchymal stem cells from mice with neurofilament light subunit gene deficiency.
Chao YX; He BP; Cao Q; Tay SS
Neurosci Lett; 2007 May; 417(3):240-5. PubMed ID: 17395374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
